CIBC World Market
BSX.PRA

CIBC World Market’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

CIBC World Market’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,050
Closed -$341K – 1346
2020
Q3 		$341K Buy
+3,050
New +$342K ﹤0.01% 931

Other funds holding BSX.PRA

Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
RA
Rational Advisors Huntington, New York $1.09B AUM 11.58% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
CWM
Calamos Wealth Management Naperville, Illinois $2.91B AUM 25.59% 1-Year Est. Return

CIBC World Market's BSX.PRA Position: Q4 2020 in Review

CIBC World Market sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q4 2020, closing a stake of 3,050 shares — an estimated $341K sold.

CIBC World Market first reported a position in BSX.PRA in Q3 2020 and held it in 1 quarter. The position peaked at $341K in Q3 2020. 7 funds tracked by Wall St. Rank hold BSX.PRA as of Q4 2020.

  • CIBC World Market reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q4 2020 after selling out during the quarter.
  • CIBC World Market sold 3,050 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q4 2020, an estimated $341K.
  • CIBC World Market first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q3 2020 and held it in 1 quarter.
  • CIBC World Market's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $341K in Q3 2020.
  • 7 funds tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q4 2020.

Based on CIBC World Market's 13F filing for Q4 2020, filed 8 Feb 2021.